Skip to main content
. 2023 Jun 30;15:1124232. doi: 10.3389/fnagi.2023.1124232

TABLE 1.

Baseline characteristics and predictors for PDND and PDID subgroups.

Characteristic M (SD) Total sample PDND PDID % Missing at baseline
N 48 34 14 0
PD duration (years) 8.9 (4.5) 8.6 (4.4) 9.5 (5.1) 0
UPDRS part III 16.6 (8.1) 14.4 (7.0) 21.7 (8.5) 0
Modified Hoehn and Yahr 2.2 (0.7) 2.0 (0.5) 2.6 (0.7) 0
Age (years)
Range
71.6 (4.77)
65 – 84
70.0 (3.53)
65 – 77
75.4 (5.33)***
66 – 84
0
Sex n (% Female) 21 (43.8) 13 (38.2) 8 (57.1) 0
Education (years) 14.1 (2.96) 14.3 (3.20) 13.6 (2.31) 0
Gait speed (standardized time in sec) 0.411 (1.59) −0.076 (0.635) 1.59 (2.44)*** 0
Gait steps (standardized number of steps) 0.420 (1.55) −0.082 (0.568) 1.64 (2.36)*** 0
Balance (standardized time; sec) 8.82 (4.40) 10.2 (3.82) 5.57 (4.09)*** 0
Finger dexterity (number of taps in 60 sec) 114.8 (25.3) 121.6 (24.6) 98.2 (19.2)** 0
Visual acuity (feet)a 34.9 (15.5) 32.6 (13.4) 40.4 (19.2) 0
Smell (number correct out of 12) 6.60 (2.92) 6.94 (2.74) 5.79 (3.26) 2.1
APOE n (ε2 + , ε3ε3, ε4 +)b (6, 35, 7) (5, 25, 4) (1, 10, 3) 0
MTHFR n (CC, CT, TT) (20, 23, 4) (14, 17, 3) (6, 6, 1) 2.1
Third ventricle volume (cm3)c 1.08 (0.311) 0.989 (0.249) 1.34 (0.324)*** 2.1
Fourth ventricle volume (cm3)c 1.25 (0.270) 1.26 (0.291) 1.21 (0.210) 2.1
White matter hyperintensities (cm3)c 2.54 (2.55) 2.33 (2.47) 3.09 (2.77) 2.1
Cortical thickness (mm) 2.31 (0.083) 2.33 (0.073) 2.25 (0.085)** 2.1
Systolic orthostatic hypotension (mm Hg) 8.38 (15.0) 6.84 (15.2) 13.3 (14.0) 12.5
Diastolic orthostatic hypotension (mm Hg) 2.00 (10.7) 0.69 (9.44) 6.20 (13.6) 12.5
Pulse pressure (mm Hg) 47.5 (8.33) 47.1 (8.34) 48.6 (8.52) 0
Heart rate (beats/min) 69.1 (9.85) 68.8 (9.24) 69.9 (11.5) 0
Creatinine (mg/dL) 84.6 (15.2) 87.6 (14.4) 77.4 (15.3)* 0
Homocysteine (mcmol/L) 13.5 (3.73) 13.4 (4.04) 13.7 (2.96) 0
Vitamin B12 (pmol/g) 294.6 (110.7) 293.1 (102.0) 298.1 (133.9) 0
Triglyceride (mmol/L) 1.12 (0.459) 1.07 (0.430) 1.22 (0.525) 2.1
Cholesterol HDL ratio (mg/dL) 3.61 (0.825) 3.49 (0.726) 3.89 (0.995) 2.1
Up-regulated metabolite panel 1.32 (0.532) 1.17 (0.414) 1.80 (0.608)*** 12.5
Down-regulated metabolite panel 0.853 (0.647) 0.932 (0.710) 0.600 (0.281) 12.5
Immediate word recall (total correct) 37.2 (10.7) 39.8 (10.5) 31.0 (8.87)** 0
Trail A (sec) 50.7 (18.3) 44.1 (12.1) 66.9 (21.1)*** 0
Trail B (sec) 139.5 (78.8) 113.1 (63.3) 203.8 (77.5)*** 0
Simple reaction time (ms) 383.4 (101.7) 370.1 (73.3) 415.7 (148.8) 0
Four choice reaction time (ms) 1052.6 (251.7) 962.3 (141.0) 1258.9 (325.5)*** 4.2
Depression (total out of 15) 1.87 (2.38) 1.38 (1.60) 3.07 (3.45)* 0
NPI-sleep (frequency × severity) 1.50 (2.75) 1.82 (3.04) 0.71 (1.73) 0
NPI-anxiety (frequency × severity) 0.54 (1.25) 0.47 (1.19) 0.71 (1.44) 0
Activities of Daily Living (% independence) 88.6 (8.80) 91.5 (4.69) 81.8 (12.3)*** 0
Body mass index (kg/m2) 27.4 (5.14) 26.6 (4.17) 29.1 (6.82) 0
SMMSE (total out of 30) 28.1 (1.70) 28.6 (1.44) 26.8 (1.63)*** 0
MoPaRDS (total out of 8) 3.04 (1.54) 2.56 (1.42) 4.21 (1.19)*** 0

aWhat this person sees at 20 feet, an average person sees at x feet, x reported. bε2ε4 (n = 1) grouped with ε4 + . cnormalized using the proportional approach (area of interest/intracranial volume). PDND, Parkinson’s disease with no dementia; PDID, Parkinson’s disease with incipient dementia; PD, Parkinson’s disease; UPDRS, Unified Parkinson’s Disease Rating Scale; NPI, Neuropsychiatric Inventory Questionnaire; SMMSE, Standardized Mini Mental State Exam; MoPaRDS, Montreal Parkinson Risk of Dementia Scale. Baseline variables for PDID significantly differed from PDND *p < 0.05, **p < 0.01, and ***p < 0.001.